Viewing Study NCT06486350


Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-03-24 @ 10:02 AM
Study NCT ID: NCT06486350
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2024-06-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: IL-6: A Marker for AML Chemo Sensitivity
Sponsor: Fujian Medical University Union Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module References Module